BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1772349)

  • 1. [Eosinophil activation in acute asthma attacks evaluated by electronmicroscopic findings of eosinophils and the concentration of eosinophil cationic protein in sputum].
    Oohashi Y; Motojima S; Kushima A; Tateishi K; Fukuda T; Makino S
    Arerugi; 1991 Oct; 40(10):1265-71. PubMed ID: 1772349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Creola bodies and the eosinophil cationic protein in sputum in acute asthmatic attacks with respect to their clinical significance].
    Ogata H; Motojima S; Fukuda T; Makino S
    Arerugi; 1990 Dec; 39(12):1567-75. PubMed ID: 2096802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A basic study on the plasma and serum levels of eosinophil cationic protein (ECP) in bronchial asthma].
    Yasuba H; Satake N; Kino T; Izumi T; Kawaguchi H
    Arerugi; 1991 Oct; 40(10):1282-8. PubMed ID: 1772351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurement of serum and sputum eosinophil cationic protein concentrations in asthma].
    Motojima S; Ogata H; Tateishi K; Fukuda T; Makino S; Koseki T; Adachi T; Kihara N
    Arerugi; 1995 Nov; 44(11):1272-81. PubMed ID: 8857106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of cytokine and eosinophil cationic protein concentrations in sputum of asthmatic patients].
    Deng H; Sun B; Zhan X
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Feb; 21(2):108-10. PubMed ID: 11263383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fundamental studies on measurement of the eosinophil cationic protein in sputum from patients with bronchial asthma].
    Motojima S; Tateishi K; Kushima A; Ohashi Y; Fukuda T; Makino S
    Arerugi; 1991 Feb; 40(2):100-7. PubMed ID: 2069509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of eosinophil cationic protein in asthmatic children].
    Tanimoto K
    Arerugi; 1996 Jun; 45(6):546-53. PubMed ID: 8776949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophil activity reflects clinical status in patients with asthma before and during a prednisolone course.
    Skedinger M; Halldén G; Lundahl J; Hed J; Zetterström O
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):250-5. PubMed ID: 7552927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sputum eosinophilia in Churg-Strauss syndrome.
    Meziane H; Maakel ML; Vachier I; Bousquet J; Chanez P
    Respir Med; 2001 Oct; 95(10):799-801. PubMed ID: 11601744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The correlational analysis assessment of exacerbation in bronchial asthma and treatment efficacy].
    Anaev EKh; Cherniaev AL; Chernik AV; Chuchalin AG
    Ter Arkh; 1996; 68(3):55-8. PubMed ID: 8744107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurement of serum eosinophil cationic protein levels in bronchial asthma].
    Hasegawa M; Fujisawa T; Komada M; Uchida Y; Haibara C
    Arerugi; 1991 Mar; 40(3 Pt 1):173-80. PubMed ID: 2053855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of salmeterol on the number of hypodense eosinophils, eosinophilic cationic protein levels ECP in serum, bronchial hyperresponsiveness and lung function test in patients with bronchial asthma].
    Chazan R; Grubek-Jaworska H; Hermanowicz-Salomon J; Droszcz W
    Pol Merkur Lekarski; 1997 Oct; 3(16):180-2. PubMed ID: 9461726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum eosinophil cationic protein as a predictor of disease activity in acute and chronic asthma.
    Onadeko BO; Khadadah ME; Mustafa HT; Ezeamuzie CI; Marouf R; Khamis A; Sugathan TN
    East Afr Med J; 1999 Sep; 76(9):524-9. PubMed ID: 10685325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence oc glycocorticoid therapy on sputum ECP concentration in symptomatic patients with bronchial asthma].
    Hermanowicz-Salamon J; Grubek-Jaworska H; Wrońska J; Droszcz W; Chazan R
    Pneumonol Alergol Pol; 2002; 70(11-12):527-35. PubMed ID: 12884561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophil cationic protein as a serological marker of disease activity in childhood bronchial asthma.
    Badr-el-Din OM; el-Sawy IH; el-Azzouni OE; Badr-el-Din MM; Salem AM
    East Mediterr Health J; 1999 Jul; 5(4):664-75. PubMed ID: 11338688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma.
    Fujimoto K; Kubo K; Matsuzawa Y; Sekiguchi M
    Chest; 1997 Nov; 112(5):1241-7. PubMed ID: 9367463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are sputum eosinophil cationic protein and eosinophils differently associated with clinical and functional findings of asthma?
    Cianchetti S; Bacci E; Ruocco L; Pavia T; Bartoli ML; Cardini C; Costa F; Di Franco A; Malagrinò L; Novelli F; Vagaggini B; Celi A; Dente F; Paggiaro P
    Clin Exp Allergy; 2014; 44(5):673-80. PubMed ID: 24245689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prednisolone on eosinophils, IL-5, eosinophil cationic protein, EG2+ eosinophils, and nitric oxide metabolites in the sputum of patients with exacerbated asthma.
    Jang AS; Choi IS; Koh YI; Jeong TK; Lee KY; Kim YS; Lee JU; Park CS
    J Korean Med Sci; 2000 Oct; 15(5):521-8. PubMed ID: 11068988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between IgA antibody and eosinophil cationic protein levels in induced sputum from asthmatic patients.
    Nahm DH; Park HS
    Clin Exp Allergy; 1997 Jun; 27(6):676-81. PubMed ID: 9208189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced sputum to assess airway inflammation: a study of reproducibility.
    Spanevello A; Migliori GB; Sharara A; Ballardini L; Bridge P; Pisati P; Neri M; Ind PW
    Clin Exp Allergy; 1997 Oct; 27(10):1138-44. PubMed ID: 9383253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.